Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 71
Filter
Add more filters

Country/Region as subject
Affiliation country
Publication year range
1.
J Allergy Clin Immunol ; 154(3): 644-656, 2024 Sep.
Article in English | MEDLINE | ID: mdl-38761998

ABSTRACT

BACKGROUND: Previous studies implied that local M2 polarization of macrophage promoted mucosal edema and exacerbated TH2 type inflammation in chronic rhinosinusitis with nasal polyps (CRSwNP). However, the specific pathogenic role of M2 macrophages and the intrinsic regulators in the development of CRS remains elusive. OBJECTIVE: We sought to investigate the regulatory role of SIRT5 in the polarization of M2 macrophages and its potential contribution to the development of CRSwNP. METHODS: Real-time reverse transcription-quantitative PCR and Western blot analyses were performed to examine the expression levels of SIRT5 and markers of M2 macrophages in sinonasal mucosa samples obtained from both CRS and control groups. Wild-type and Sirt5-knockout mice were used to establish a nasal polyp model with TH2 inflammation and to investigate the effects of SIRT5 in macrophage on disease development. Furthermore, in vitro experiments were conducted to elucidate the regulatory role of SIRT5 in polarization of M2 macrophages. RESULTS: Clinical investigations showed that SIRT5 was highly expressed and positively correlated with M2 macrophage markers in eosinophilic polyps. The expression of SIRT5 in M2 macrophages was found to contribute to the development of the disease, which was impaired in Sirt5-deficient mice. Mechanistically, SIRT5 was shown to enhance the alternative polarization of macrophages by promoting glutaminolysis. CONCLUSIONS: SIRT5 plays a crucial role in promoting the development of CRSwNP by supporting alternative polarization of macrophages, thus providing a potential target for CRSwNP interventions.


Subject(s)
Macrophages , Mice, Knockout , Nasal Polyps , Rhinitis , Sinusitis , Sirtuins , Animals , Sinusitis/immunology , Sinusitis/pathology , Sinusitis/genetics , Humans , Chronic Disease , Macrophages/immunology , Macrophages/metabolism , Sirtuins/genetics , Sirtuins/metabolism , Mice , Rhinitis/immunology , Rhinitis/pathology , Rhinitis/genetics , Nasal Polyps/immunology , Nasal Polyps/pathology , Male , Female , Adult , Middle Aged , Eosinophilia/immunology , Macrophage Activation/immunology , Macrophage Activation/genetics , Mice, Inbred C57BL , Eosinophils/immunology , Th2 Cells/immunology , Rhinosinusitis
2.
Inorg Chem ; 62(14): 5543-5552, 2023 Apr 10.
Article in English | MEDLINE | ID: mdl-36995797

ABSTRACT

Bistable materials with multiphysical channels, such as optical, electrical, and magnetic properties, have been paid dramatic attention due to their alternativity of the signal status in electronic devices. Herein, three stable supramolecular radicals ([(NH3-TEMPO)(18-crown-6)][XF6] (1, X = P; 2, X = As; 3, X = Sb)) were synthesized and characterized. The former two molecules present ferroelectric phase transitions around 381.7 and 382.7 K, respectively, with bistability in dielectric property and second-harmonic generation (SHG) effect, which are first found in supramolecular radicals. Their ferroelectric transition and bistable properties are generated from a net polar crystal structure owing to the static ordered packing of NH3-TEMPO radical cations in the low-temperature phase (LTP) to a nonpolar structure owing to a distinctive symmetric scissoring motion of NH3-TEMPO radical cations between two 18-crown-6 molecules in the high-temperature phase (HTP). Both of them exhibit paramagnetic properties in HTP and LTP states since no intermolecular spin-spin interaction occurs due to the long distances among the radicals in their crystals. These results make us possible to design bistable optoelectronic radical materials with bistability in magnetic property in the future.

3.
Pediatr Surg Int ; 39(1): 206, 2023 May 29.
Article in English | MEDLINE | ID: mdl-37248361

ABSTRACT

IMPORTANCE: Multiple studies indicate a possible correlation between ADD3 rs2501577 and biliary atresia susceptibility; however, a conclusive determination has yet to be made. OBJECTIVE: Investigate the role of ADD3 rs2501577 in biliary atresia susceptibility across diverse populations. DATA SOURCES: The study protocol has been registered on PROSPERO, an international platform for systematic review registration (PROSPERO ID: CRD42023384641). The following databases will be searched until February 1, 2023: PubMed, Embase, Cochrane, CBM, Web of Science, and CNKI. STUDY SELECTION: Eight studies were selected from seven papers to assess the data. A total of 7651 participants were included, consisting of 1662 in the BA group and 5989 in the NC group. DATA EXTRACTION AND SYNTHESIS: Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed while conducting the systematic reviews and meta-analyses. Two authors independently assessed the quality of the included studies using the Newcastle-Ottawa Quality Assessment Scale. The significance of the pooled odds ratio (OR) was evaluated with a Z test, and statistical heterogeneity across studies was assessed using the I2 and Q statistics. Publication bias was assessed using Egger's and Begg's tests. MAIN OUTCOME(S) AND MEASURE(S): The primary study outcome was the development of biliary atresia. Subgroup analysis was performed based on race, region, and assessment of Hardy-Weinberg equilibrium (HWE). RESULTS: The studies indicate that the ADD3 rs2501577 susceptibility locus increases the risk of developing biliary atresia, regardless of allelic, homozygote, dominant, and recessive gene inheritance models. Furthermore, ADD3 has been found to be associated with apoptosis, cell cycle, and cell damage repair based on functional analysis. CONCLUSIONS AND RELEVANCE: The ADD3 rs2501577 polymorphic locus is associated with an increased risk of biliary atresia, particularly in Asian populations. This study recommends further investigation of the ADD3 rs2501577 locus in Asian populations to validate its role in the diagnosis of biliary atresia.


Subject(s)
Biliary Atresia , Humans , Biliary Atresia/genetics , Polymorphism, Single Nucleotide/genetics , Calmodulin-Binding Proteins/genetics , Odds Ratio
4.
Neoplasma ; 69(6): 1253-1269, 2022 Dec.
Article in English | MEDLINE | ID: mdl-35951454

ABSTRACT

Osteopontin (OPN) is a multifunctional phosphorylated glycoprotein that is expressed at significantly elevated levels in various cancers. OPN overexpression is closely associated with the development of cancer progression such as proliferation, metastasis, angiogenesis, apoptosis resistance, drug resistance, and immunosuppression, and may also be an independent prognostic biomarker for a variety of cancers. This review broadly summarizes the mechanisms that regulate the expression of downstream oncogenic molecules after OPN binds to integrin receptors or CD44 receptors, which involve a complex intracellular "signaling traffic network" (including key kinases, signaling pathways, and transcription factors). In addition, we review the prognostic value of OPN, OPN synergistic downstream oncogenic molecules in the female breast, non-small cell lung, prostate, colorectal, gastric, and hepatocellular carcinomas. The prognostic value of OPN in tissues or blood may vary due to differences in study subjects or detection methods, and this aspect of the study requires further systematization with a view to applying the detection of OPN to clinical applications. Importantly, based on the fact that the oncogenic effect of OPN correlates with the expression of the above-mentioned oncogenic molecules, this work may provide some help in the study of combination therapy targeting OPN and the above-mentioned oncogenic molecules.


Subject(s)
Neoplasms , Osteopontin , Humans , Carcinogenesis , Carcinogens , Prognosis
5.
Opt Express ; 29(2): 2037-2048, 2021 Jan 18.
Article in English | MEDLINE | ID: mdl-33726405

ABSTRACT

Nowadays, the manipulation of the chiral light field is highly desired to characterize chiral substances more effectively, since the chiral responses of most molecules are generally weak. Terahertz (THz) waves are related to the vibration-rotational energy levels of chiral molecules, so it is significant to actively control and enhance the chirality of THz field. Here, we propose a metal/magneto-optical (MO) hybrid Pancharatnam-Berry (PB) phase structure, which can serve as tunable broadband half-wave plate and control the conversion of THz chiral states with the highest efficiency of over 80%. Based on this active PB element, MO PB metasurfaces are proposed to manipulate THz chiral states as different behaviors: beam deflector and scanning, Bessel beam, and vortex beam. Due to the magnetic-tunablibity, these proposed MO PB metasurfaces can be turned from an "OFF" to "ON" state by changing the external magnetic field. We further investigate the near-field optical chirality and the chirality enhancement factors in far field of the chiral Bessel beam and vortex beam, achieving the superchiral field with the highest chiral enhancement factor of 40 for 0th Bessel beam. These active, high efficiency and broadband chiral PB metasurfaces have promising applications for manipulation the THz chiral light and chiroptical spectroscopic techniques.

6.
Analyst ; 146(5): 1725-1733, 2021 Mar 08.
Article in English | MEDLINE | ID: mdl-33459316

ABSTRACT

Protein drugs showing strong pharmaceutical activity, high specificity, and low toxicity and side effects have drawn extensive attention in the field of life sciences and medicine. Precise evaluation of the function of these drugs requires accurate and sensitive detection methods. Here, we report a novel chromatography-tandem mass spectrometry (LC-MS/MS) method for sensitive and selective detection of protein drugs. Magnetic nanoparticles (Apt29@MNPs) were functionalized by thrombin aptamers, and quantum dots (Apt15@ss@QDs) were dual-functionalized with quantitative thrombin aptamers and small molecules with high ionization efficiency as the mass barcode. After Apt29@MNPs specifically purify and enrich thrombin from biological samples, they can form a nano "sandwich structure" when Apt15@ss@QDs are added, resulting in the release of the mass barcode for LC-MS/MS analysis via the cutting of the disulfide bond. Since there is a higher quantitative molecular ratio of mass barcode to thrombin in the nano-"sandwich structure", quantitative detection of thrombin with high sensitivity and selectivity can be achieved via the LC-MS/MS detection of the mass barcode with high ionization efficiency rather than thrombin, which effectively avoids the disadvantages of direct protein detection by mass spectrometry. The established method for thrombin detection shows a good linear relationship in a concentration range of 0.00115-1.15 nM with a limit of detection (LOD) of 0.0007 nM. The present work provides a new approach for the effective and sensitive quantitative analysis of protein drugs and would be of great significance in promoting the development of protein drugs and clinical applications.


Subject(s)
Tandem Mass Spectrometry , Thrombin , Chromatography, Liquid , Limit of Detection , Proteins
7.
Opt Express ; 28(14): 21062-21071, 2020 Jul 06.
Article in English | MEDLINE | ID: mdl-32680153

ABSTRACT

The wafer-scale La:YIG single crystal thick films were fabricated on a three-inch gadolinium gallium garnet (GGG) substrate by liquid phase epitaxy method. The terahertz (THz) optical and magneto-optical properties of La:YIG film were demonstrated by THz time domain spectroscopy (THz-TDS). The results show that a high refractive index of approximately 4.09 and a low absorption coefficient of 10-50 cm-1 from 0.1 to 1.6 THz for this La:YIG film. Moreover, the THz Faraday rotation effect of La:YIG film was measured by the orthogonal polarization detection method in THz-TDS system, which can be actively manipulated by a weak longitudinal magnetic field of up to 0.155 T. With 5 samples stacked together, the Faraday rotation angle varies linearly from -15° to 15°, and the Verdet constant of La:YIG is about 100 °/mm/T within the saturation magnetization. This magneto-optical single crystal thick film with large area shows low loss, high permittivity and strong magneto-optical effect in the THz regime, which will be widely used in magneto-optical polarization conversion, nonreciprocal phase shifter and isolator for THz waves.

8.
Chirality ; 30(12): 1277-1286, 2018 12.
Article in English | MEDLINE | ID: mdl-30321480

ABSTRACT

Rabeprazole is an effective proton pump inhibitor to treat acid-related diseases. To achieve the simultaneous determination of rabeprazole enantiomers in human plasma, a chiral LC-MS/MS method was developed and validated. Acetonitrile including 0.1% ammonium were used as protein precipitating agent. Analytes were separated within 8 minutes on a Chiralpak IC column (4.6 mm × 150 mm, 5 µm). The mobile phase was 10 mM ammonium acetate including 0.2% acetic acid-acetonitrile (35:65, v/v). An API 4000 mass spectrometer was used as detector for the analysis, and the multiple reactions monitoring transitions of m/z 360.1 â†’ 242.2 and 346.1 â†’ 198.1 were opted for quantifying rabeprazole enantiomers and internal standard. Matrix effects were not apparent for each enantiomer and internal standard (esomeprazole), the calibration curves were linear over the concentration of 0.500 to 400 ng·mL-1 , the intra-run precisions were below 5.4%, the inter-run precisions were below 9.9%, and the accuracy was between -9.2% and 9.3%. There was no chiral inversion observed during sample storage, preparation procedure, and analysis, demonstrating that analytes were stable in this study. This method was applied to the stereoselective pharmacokinetic study of (R)-(+)- and (S)-(-)-rabeprazole after oral administration of 10-mg rabeprazole sodium enteric-coated tablet in healthy Chinese subjects.


Subject(s)
Chromatography, Liquid/methods , Rabeprazole/chemistry , Rabeprazole/pharmacokinetics , Tandem Mass Spectrometry/methods , Administration, Oral , Adolescent , Adult , Calibration , Drug Stability , Humans , Limit of Detection , Rabeprazole/administration & dosage , Rabeprazole/blood , Reproducibility of Results , Sensitivity and Specificity , Stereoisomerism , Tablets, Enteric-Coated
9.
Anal Chem ; 89(1): 974-979, 2017 01 03.
Article in English | MEDLINE | ID: mdl-27936593

ABSTRACT

This paper reports on a novel method for determining the specific surface area (SSA) of shale via headspace gas chromatography (HS-GC). The method is based on the water adsorption on the surface of shale sample after achieving phase equilibrium at an elevated temperature (i.e., heating at 125 °C for 48 h). A mathematical model shows that the SSA can be determined from the signal of the vapor water released during HS-GC analysis. The results obtained by this method correlated well (R2 = 0.992) with data obtained by the reference BET method. Because the phase equilibrium step for multiple samples can be conducted simultaneously, and because the phase re-equilibrium step is much faster in the HS-GC measurement, the present method is more efficient for batch sample testing.

10.
Acta Radiol ; 58(1): 41-45, 2017 Jan.
Article in English | MEDLINE | ID: mdl-26924836

ABSTRACT

BACKGROUND: Anastomotic stenosis is an infrequent but life-threatening complication after gastrojejunostomy (Billroth II). Tubular or single tubular stents have limited efficacy due to the particular anatomy. PURPOSE: To assess the feasibility of a Y-shaped, fully-coated, self-expandable, metallic stent (SEMS) for anastomotic stenosis after gastrojejunostomy (Billroth II). MATERIAL AND METHODS: Between January 2008 and August 2014, 14 patients (10 with gastric carcinoma and four with duodenal ulcers) had anastomotic stenoses following Billroth II reconstructions. Eight patients with gastric cancer had tumor recurrence near the anastomosis; two had benign strictures. The four duodenal ulcer patients had benign stenoses. An integrated Y-shaped, fully coated SEMS was designed to accord with the anatomy of residual gastrojejunal anastomotic strictures. Fourteen stents were inserted under fluoroscopic control. Follow-up was at 1, 3, 9, and 12 months, and then annually. RESULTS: All 14 stents were inserted successfully at the first attempt with a technical success rate of 100%. After stenting, abdominal symptoms resolved in all patients. All patients were followed up for 4-27 months (mean, 13.9 months). One of the eight recurrent cases died of multiple tumor metastases and liver failure after 7 months, without obstruction symptoms. In all six patients with benign anastomotic stenosis, the stents were removed successfully without complication and with no evidence of restenosis based on clinical evaluation and imaging. CONCLUSION: A Y-shaped, fully-coated SEMS proved to be a feasible and minimally invasive procedure for treating anastomotic stenosis after gastrojejunostomy (Billroth II).


Subject(s)
Gastric Bypass/adverse effects , Gastric Outlet Obstruction/etiology , Gastric Outlet Obstruction/surgery , Stents , Adult , Aged , Coated Materials, Biocompatible , Elastic Modulus , Equipment Failure Analysis , Feasibility Studies , Female , Gastric Outlet Obstruction/diagnostic imaging , Humans , Male , Middle Aged , Prosthesis Design , Treatment Outcome
11.
Acta Radiol ; 58(1): 3-9, 2017 Jan.
Article in English | MEDLINE | ID: mdl-26917786

ABSTRACT

BACKGROUND: Obstructive jaundice (OJ) is insensitive to radiation and chemotherapy, and a pathologic diagnosis is difficult to make clinically. Percutaneous transhepatic cholangiobiopsy (PTCB) is simple to perform and minimally invasive, and clinical practice has shown it to be an accurate and reliable new method for bile duct histopathologic diagnosis. PURPOSE: To investigate the value of PTCB for pathologic diagnosis of causes of OJ. MATERIAL AND METHODS: From April 2001 to December 2011, PTCB was performed in 826 consecutive patients. Data on pathologic diagnosis, true positive rate, and complications were analyzed retrospectively. Patients with negative pathologic findings were diagnosed using clinical, imaging, laboratory, and prognostic data. The feasibility and safety of PTCB for OJ were evaluated and true positive rates for biliary carcinoma and non-biliary carcinoma compared. RESULTS: PTCB was successful in all cases. Of 740 patients clinically diagnosed with malignant biliary stricture and 86 with benign biliary stricture, 727 received a positive pathologic diagnosis; in 99, the pathologic findings were considered false negative. The true positive rate for PTCB was 88.01% overall, differing significantly for biliary and non-biliary carcinoma (χ2 = 12.87, P < 0.05). Malignancy accounted for 89.59% of OJ cases; well, moderately, and poorly differentiated carcinoma represented 57.88%, 19.97%, and 22.15%. Biliary adenocarcinoma was the predominant malignant pathologic type (96.41%). Transient bilemia, bile leakage, and temporary hemobilia occurred in 47, 11, and 28 cases, respectively, with no serious complications. CONCLUSION: PTCB is safe, feasible, and simple, with a high true positive rate for definitive diagnosis of OJ causes. Well differentiated adenocarcinoma was the predominant pathologic type.


Subject(s)
Biliary Tract Neoplasms/diagnosis , Biliary Tract Neoplasms/epidemiology , Biopsy/statistics & numerical data , Jaundice, Obstructive/diagnosis , Jaundice, Obstructive/epidemiology , Postoperative Complications/epidemiology , Adult , Aged , Aged, 80 and over , Biliary Tract Neoplasms/pathology , Biopsy/methods , Causality , China/epidemiology , Comorbidity , Female , Humans , Jaundice, Obstructive/pathology , Male , Middle Aged , Postoperative Complications/diagnostic imaging , Prevalence , Reproducibility of Results , Risk Factors , Sensitivity and Specificity
12.
J Neuroinflammation ; 13(1): 214, 2016 08 30.
Article in English | MEDLINE | ID: mdl-27577933

ABSTRACT

BACKGROUND: Aconiti brachypodi Radix (Xue-shang-yi-zhi-hao) has been prescribed to manage chronic pain, arthritis, and traumatic injuries. Bullatine A, a C20-diterpenoid alkaloid, is one of its principle effective compounds. This study aimed to investigate the anti-hypersensitivity of bullatine A in a variety of rat pain models and explore its mechanisms of action. METHODS: Rat neuropathic pain, inflammatory pain, diabetic neuropathic pain, and bone cancer pain models were used. Dynorphin A and pro-inflammatory cytokines were measured in the spinal cord and cultured primary microglia. Double immunofluorescence staining of dynorphin A and glial and neuronal cellular markers was also measured in the spinal cord. RESULTS: Subcutaneous and intrathecal injection of bullatine A dose-dependently attenuated spinal nerve ligation-, complete Freud's adjuvant-, diabetes-, and bone cancer-induced mechanical allodynia and thermal hyperalgesia, with the efficacies of 45-70 % inhibition, and half-effective doses of 0.9-1.9 mg/kg for subcutaneous injection. However, bullatine A was not effective in blocking acute nociceptive response in the normal condition. Bullatine A specifically stimulated dynorphin A expression in microglia in the spinal cord in vivo and cultured primary microglia in vitro; the stimulatory effects were completely inhibited by the microglial inhibitor minocycline. In contrast, bullatine A did not have an inhibitory effect on peripheral nerve injury- or lipopolysaccharide-induced pro-inflammatory cytokine expression. The spinal anti-allodynic effects of bullatine A were entirely blocked by intrathecal injection of minocycline, the specific dynorphin A antiserum, and the selective k-opioid receptor antagonist. CONCLUSIONS: We, for the first time, demonstrate that bullatine A specifically attenuates pain hypersensitivity, regardless of the pain models employed. The results also suggest that stimulation of spinal microglial dynorphin A expression mediates bullatine A anti-nociception in pain hypersensitivity conditions.


Subject(s)
Alkaloids/therapeutic use , Disease Models, Animal , Diterpenes/therapeutic use , Dynorphins/biosynthesis , Hyperalgesia/drug therapy , Hyperalgesia/metabolism , Spinal Cord/metabolism , Alkaloids/pharmacology , Analgesics/pharmacology , Analgesics/therapeutic use , Animals , Animals, Newborn , Cells, Cultured , Diterpenes/pharmacology , Dose-Response Relationship, Drug , Dynorphins/genetics , Female , Gene Expression , Injections, Subcutaneous , Male , Neuralgia/drug therapy , Neuralgia/metabolism , Rats , Rats, Sprague-Dawley , Rats, Wistar , Spinal Cord/drug effects
13.
Acta Radiol ; 57(12): 1524-1530, 2016 Dec.
Article in English | MEDLINE | ID: mdl-26953230

ABSTRACT

Background Cerebral venous sinus thrombosis (CVST) is a rare clinicopathological entity with substantial diagnostic and therapeutic dilemmas. The appropriate management of CVST remains to be defined. Purpose To evaluate the efficiency and safety of mechanical thrombectomy with Solitaire AB stents for the treatment of intracranial venous sinus thrombosis. Material and Methods Twenty-three consecutive patients with CVST who were treated with mechanical thrombectomy using Solitaire AB stents between January 2013 and October 2014 were retrospectively analyzed. The headache intensity was evaluated according to the visual analogue scale (VAS), and neurological function was assessed using the National Institute of Health Stroke Scale (NIHSS). Follow-up data were available for all patients for 6-14 months. Magnetic resonance imaging (MRI) and magnetic resonance venography (MRV) were performed at 3 and 6 months after neurointervention, and telephone interviews were performed monthly thereafter. The Wilcoxon signed-rank test was used to compare the evaluation data (VAS and NIHSS) at admission and discharge. Results Twenty-six Solitaire AB stents were used. No neurointervention-related complications were noted. The symptoms were significantly improved after neurointervention in all patients. The comparisons between the VAS and NIHSS evaluations at admission and discharge were significantly different ( P < 0.05). No recurrence was observed during the follow-up period. Conclusion Mechanical thrombectomy with Solitaire AB stents is safe and effective for the treatment of CVST and can significantly improve clinical symptoms. The occurrence of complications is low, and the prognosis is favorable.


Subject(s)
Sinus Thrombosis, Intracranial/surgery , Stents , Thrombectomy/methods , Adolescent , Adult , Aged , Brain/surgery , Female , Humans , Male , Middle Aged , Retrospective Studies , Treatment Outcome , Young Adult
14.
Anal Chem ; 87(21): 11072-7, 2015 Nov 03.
Article in English | MEDLINE | ID: mdl-26460174

ABSTRACT

This paper reports on a novel method for the rapid determination of the shale porosity by double headspace extraction gas chromatography (DHE-GC). Ground core samples of shale were placed into headspace vials and DHE-GC measurements of released methane gas were performed at a given time interval. A linear correlation between shale porosity and the ratio of consecutive GC signals was established both theoretically and experimentally by comparing with the results from the standard helium pycnometry method. The results showed that (a) the porosity of ground core samples of shale can be measured within 30 min; (b) the new method is not significantly affected by particle size of the sample; (c) the uncertainties of measured porosities of nine shale samples by the present method range from 0.31 to 0.46 p.u.; and (d) the results obtained by the DHE-GC method are in a good agreement with those from the standard helium pycnometry method. In short, the new DHE-GC method is simple, rapid, and accurate, making it a valuable tool for shale gas-related research and applications.

15.
Pharmacol Res ; 102: 276-85, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26546042

ABSTRACT

Both peptidic agonist exenatide and herbal agonist catalpol of the glucagon-like peptide-1 receptor (GLP-1R) are neuroprotective. We have previously shown that activation of spinal GLP-1Rs expresses ß-endorphin in microglia to produce antinociception. The aim of this study was to explore whether exenatide and catalpol exert neuroprotection via activation of the hippocampal GLP-1R/ß-endorphin pathway. The rat middle cerebral artery occlusion model was employed, and the GLP-1R immunofluorescence staining and ß-endorphin measurement were assayed in the hippocampus and primary cultures of microglia, neurons and astrocytes. The immunoreactivity of GLP-1Rs on microglia in the hippocampus was upregulated after ischemia reperfusion. Intracerebroventricular (i.c.v.) injection of exenatide and catalpol produced neuroprotection in the rat transient ischemia/reperfusion model, reflected by a marked reduction in brain infarction size and a mild recovery in neurobehavioral deficits. In addition, i.c.v. injection of exenatide and catalpol significantly stimulated ß-endorphin expression in the hippocampus and cultured primary microglia (but not primary neurons or astrocytes). Furthermore, exenatide and catalpol neuroprotection was completely blocked by i.c.v. injection of the GLP-1R orthosteric antagonist exendin (9-39), specific ß-endorphin antiserum, and selective opioid receptor antagonist naloxone. Our results indicate, for the first time, that the neuroprotective effects of catalpol and exenatide are GLP-1R-specific, and that these effects are mediated by ß-endorphin expression probably in hippocampal microglia. We postulate that in contrast to the peripheral tissue, where the activation of GLP-1Rs in pancreas islet ß-cells causes secretion of insulin to perform glucoregulation, it leads to ß-endorphin expression in microglial cells to produce neuroprotection and analgesia in the central nervous system.


Subject(s)
Glucagon-Like Peptide-1 Receptor/metabolism , Hippocampus/drug effects , Iridoid Glucosides/pharmacology , Neuroprotection/drug effects , Neuroprotective Agents/pharmacology , Peptides/pharmacology , Venoms/pharmacology , beta-Endorphin/metabolism , Animals , Cells, Cultured , Exenatide , Glucagon-Like Peptide 1/metabolism , Hippocampus/metabolism , Insulin/metabolism , Male , Microglia/drug effects , Microglia/metabolism , Neurons/drug effects , Neurons/metabolism , Rats , Rats, Wistar , Receptors, Opioid/metabolism
16.
J Vasc Interv Radiol ; 26(5): 715-21, 2015 May.
Article in English | MEDLINE | ID: mdl-25817458

ABSTRACT

PURPOSE: To determine the safety and feasibility of percutaneous transhepatic cholangiography (PTC) and intraductal radiofrequency (RF) ablation combined with biliary stent placement for malignant biliary obstruction. MATERIALS AND METHODS: Data from patients with unresectable malignant biliary obstruction who underwent PTC, intraductal RF ablation, and biliary stent placement (n = 12) or PTC and biliary stent placement only (control group; n = 14) were reviewed. Postoperative complications, jaundice remission, and stent patency were assessed. RESULTS: All procedures were successful. No severe complications (eg, biliary bleeding, perforation) occurred. Two experimental group patients developed cholangitis, which resolved with conservative treatment. The 1-week jaundice remission and 3-month stent patency rates were similar in both groups, but the 6-month stent patency rate was higher in the experimental group (P < .05). In the experimental group, one death occurred as a result of gastrointestinal hemorrhage (unrelated to stent placement) by 3 months, and there were two cases of recurrent jaundice by 6 months. The latter two patients underwent repeat PTC, ablation, and stent placement. In the control group, one death occurred as a result of hepatic failure caused by progressive jaundice at 3 months, and another death resulted from disseminated intravascular coagulation caused by jaundice recurrence at 138 days after stent placement. In addition, seven patients developed jaundice recurrence (50-151 d after stent placement). PTC and repeat stent placement were performed in these patients. CONCLUSIONS: Percutaneous transhepatic cholangiography and intraductal RF ablation combined with biliary stent placement for malignant biliary obstruction is safe and feasible and effectively prolongs stent patency time.


Subject(s)
Bile Duct Neoplasms/complications , Catheter Ablation , Cholangiography/methods , Cholestasis/diagnostic imaging , Cholestasis/surgery , Stents , Female , Humans , Male , Middle Aged , Postoperative Complications , Treatment Outcome
17.
Acta Radiol ; 56(11): 1368-72, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25406432

ABSTRACT

BACKGROUND: Anastomotic bleeding is an infrequent but life-threatening complication after stapled digestive tract anastomosis. Endovascular embolization is one of the available treatments, but precise clinical outcomes are yet to be evaluated. PURPOSE: To evaluate the efficacy and safety of endovascular embolization for managing anastomotic bleeding after stapled digestive tract anastomosis. MATERIAL AND METHODS: Twenty-eight patients were diagnosed with anastomotic bleeding after stapled digestive tract anastomosis by digital subtraction angiography (DSA). Curative effect was summed for analysis. RESULTS: All bleeding arteries were located in the stoma and were identified by contrast agent spillover by DSA. The offending arteries were superselectively catheterized and embolized with microcoils and/or gelatin sponge particles. Laboratory examinations showed normal hemoglobin and red blood cell counts when the patients' abdominal cavity drainage tubes stopped draining blood. The follow-up period was 3.2-84.7 months (median, 19.7 months). Four patients died during this time, of which two had cholangiocarcinoma, one had gastric cancer with tumor recurrence and multiple organ failure, and the final patient had a subarachnoid hemorrhage 4 months after embolization. In the surviving patients, no rebleeding occurred after embolization and no additional intervention or surgery was required. CONCLUSION: Endovascular embolization is safe and effective for managing anastomotic bleeding after stapled digestive tract anastomosis.


Subject(s)
Anastomosis, Surgical/methods , Anastomotic Leak/therapy , Digestive System Surgical Procedures , Embolization, Therapeutic/methods , Gastrointestinal Hemorrhage/therapy , Postoperative Hemorrhage/therapy , Surgical Stapling , Adolescent , Adult , Aged , Anastomotic Leak/diagnostic imaging , Angiography, Digital Subtraction , Female , Gastrointestinal Hemorrhage/diagnostic imaging , Humans , Male , Middle Aged , Postoperative Hemorrhage/diagnostic imaging , Treatment Outcome
18.
Opt Express ; 22(1): 537-46, 2014 Jan 13.
Article in English | MEDLINE | ID: mdl-24515014

ABSTRACT

We study the diffraction of optical waves by a single layer of gyromagnetic cylinders. We show that a nonvanishing rotating dipole momentum is excited in a single gyromagnetic cylinder because of the classic analog of the Zeeman effect on photonic angular momentum states (PAMSs). Consequently, different collective dipole modes are excited in a gyromagnetic cylinder array at opposite incident angles. Nonreciprocal optical diffraction effects can be observed, where the transmission and reflection coefficients depend on the sign of the incident angle. A novel phenomenon of nonreciprocal negative directional transmission is demonstrated and numerically analyzed. This work highlights the potential of PAMSs in manipulating the propagation of optical waves for various applications.

19.
Hepatogastroenterology ; 61(129): 22-6, 2014.
Article in English | MEDLINE | ID: mdl-24895787

ABSTRACT

BACKGROUND/AIMS: The appropriate selection of an anti-cancer treatment after biliary stenting for bile duct cancer and the effects of new anti-cancer treatments are unclear. To determine the clinical efficacy of metallic biliary stents combined with different anticancer treatments in the management of bile duct cancer. METHODOLOGY: We compared 49 patients with bile duct cancer who underwent biliary stenting plus anticancer treatment with 60 patients who underwent stenting alone (controls) in our hospital, between December 1998 and December 2012. RESULTS: In the combined-treatment group, 23 patients underwent three-dimensional radiation therapy, 21 underwent chemotherapy, and 5 underwent both three-dimensional radiation therapy and chemotherapy. The survival rate (chi2 = 41.563, P = 0.000) and duration of stent patency (chi2 = 50.268, P = 0.000) were significantly greater in the combined-treatment group than the control group. Adverse reactions were observed .The patients in the combined-treatment group developed nausea, vomiting and leukopenia, which were cured with symptomatic treatment. No biliary stent-related complications occurred in either group. CONCLUSIONS: Metallic biliary stent insertion combined with different anti-cancer treatments can increase survival and stent patency rates in bile duct cancer patients. This combination treatment was safe and effective.


Subject(s)
Bile Duct Neoplasms/therapy , Stents , Adult , Aged , Aged, 80 and over , Antineoplastic Agents/therapeutic use , Biomarkers, Tumor/analysis , Chemoembolization, Therapeutic , Chemotherapy, Adjuvant , Cholangiography , Combined Modality Therapy , Female , Fluoroscopy , Humans , Male , Metals , Middle Aged , Radiotherapy, Adjuvant , Survival Rate , Tomography, X-Ray Computed , Treatment Outcome
20.
Hepatogastroenterology ; 61(134): 1519-22, 2014 Sep.
Article in English | MEDLINE | ID: mdl-25436335

ABSTRACT

BACKGROUND/AIMS: To assess the feasibility and efficacy of combined T/Y biliary stent for the bilateral drainage of biliary obstruction caused by Bismuth-Corlett type IV hilar cholangiocarcinoma. METHODOLOGY: Eleven patients with unresectable malignant hilar biliary obstruction of Bismuth-Corlett type IV underwent placement of combined T/Y biliary stent. After unilateral or bilateral percutaneous transhepatic cholangiography, "T" or "Y" type combined biliary metal stents were placed based on the intersection angle of the left and right intrahepatic bile ducts. RESULTS: Technical success of stent placement was achieved for all 11 cases. Eight patients had "T" type and three cases had "Y" type stents placement. Internal drainage achieved with no major complications developed, except for minor hemorrhage occurred for two patients (18.2%). The survival time, liver function including bilirubin concentration and degree of dilation of the bile duct improved. CONCLUSIONS: The combined T/Y biliary stent may be feasible and effective for bilaterally drainage of malignant hilar biliary obstruction, this operation is easy to perform, less invasive and shows a good effect of biliary drainage.


Subject(s)
Bile Duct Neoplasms/complications , Bile Ducts, Intrahepatic , Cholangiocarcinoma/complications , Cholestasis/therapy , Drainage/instrumentation , Stents , Adult , Aged , Bile Duct Neoplasms/pathology , Bile Ducts, Intrahepatic/diagnostic imaging , Bile Ducts, Intrahepatic/pathology , Cholangiocarcinoma/pathology , Cholestasis/diagnosis , Cholestasis/etiology , Drainage/adverse effects , Feasibility Studies , Female , Humans , Male , Metals , Middle Aged , Prosthesis Design , Punctures , Radiography , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL